Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-136-5 | CAS number: -
Endpoint summary
Administrative data
Description of key information
oral LD50 in rats > 15000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 15 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The evaluation of Acute toxicity of the substance has been based on a study conducted on the Similar Substance 01. The complete hypothesis and justification for the read across approach has been attached in section 13.
Despite the key study was not carried out according to a OECD Guideline, but to an internal method, the test turns out to be sufficiently detailed (even if pathology was not performed). Groups of 5 male and 5 female rats were treated with various single doses of the compound, diluted in distilled water by gavage. Symptoms and mortality after administration were recorded during an observation period of 8 days.
The acute oral LD50 in rats was established to be greater than 15000 mg/kg.
Justification for selection of acute toxicity – oral endpoint
The test results/procedures described do not totally comply with a testing guideline (OECD 401) but they are sufficient in quantity and quality to permit an evaluation of the effects of the test substance.
Justification for classification or non-classification
According to the CLP Regulation (EC 1272/2008), substances can be allocated to one of four toxicity categories based on acute toxicity by the oral, dermal or inhalation route according to the numeric criteria. Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE).
In the case of oral exposure route, the acute toxicity hazard categories and acute toxicity estimates (ATE) defining the respective categories are:
- category 1: ATE ≤ 5 mg/kg bw
- category 2: 5 < ATE ≤ 50 mg/kg bw
- category 3: 50 < ATE ≤ 300 mg/kg bw
- category 4: 300 < ATE ≤ 2000 mg/kg bw
The acute oral LD50 in rats was established to be greater than 15000 mg/kg bw.
Therefore, the substance is not classified for oral acute toxicity according to the CLP Regulation (EC n. 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
